(Q39034922)

English

Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses.

scientific article published on 26 February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

P Mitchell

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

N Thatcher

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M A Socinski

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

E Wasilewska-Tesluk

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

K Horwood

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A Szczesna

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C Martín

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Zukin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C Helwig

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Falk

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C Butts

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

F A Shepherd

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1134-1142

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25722382%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV104

21 January 2018

Is consolidation chemotherapy after concurrent chemo-radiotherapy beneficial for patients with locally advanced non-small-cell lung cancer? A pooled analysis of the literature

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV104

21 January 2018

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV104

21 January 2018

MUC1 as a target antigen for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV104

21 January 2018

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV104

21 January 2018

Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV104

21 January 2018

Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV104

21 January 2018

Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV104

21 January 2018

Antitumor effects of L-BLP25 antigen-specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV104

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39034922&oldid=1636083263"